Overview
Immuno-Oncology Technology, published by Elsevier BV (United Kingdom), published 1,180 papers in 2021–2025, and its papers received 1,562 citations in those years. Its h-index is 22 and its two-year mean citedness is 0.43. On the ITS Journal Score it ranks #17,615 of 62,158 ranked journals and #3,782 of 8,757 in Medicine.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 19 | 214 | 19 |
| 2021 | 19 | 124 | 19 |
| 2022 | 270 | 721 | 270 |
| 2023 | 229 | 423 | 229 |
| 2024 | 255 | 243 | 255 |
| 2025 | 407 | 51 | 407 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Journal of Immunotherapy | Medicine | 69.8 | 240 | 35% |
| Journal for ImmunoTherapy of Cancer | Medicine | 83.3 | 9,771 | 100% |
| Cancer Immunology Immunotherapy | Immunology and Microbiology | 83.7 | 1,451 | 100% |
| Journal of Cancer Immunology | Medicine | 48.2 | 90 | 98% |
| OncoImmunology | Immunology and Microbiology | 82.9 | 796 | 100% |
| Cancer Immunology Research | Medicine | 76.7 | 1,553 | 32% |
| Journal of Immunotherapy and Precision Oncology | Medicine | 60.4 | 151 | 100% |
| Immunotherapy | Immunology and Microbiology | 71.9 | 664 | 48% |
Identity and sources
- ISSN-L: 2590-0188
- Print ISSN: 2590-0188
- Publisher: Elsevier BV
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: Not yet checked
- OpenAlex: S4210240197
- Journal website: www.journals.elsevier.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Immuno-Oncology Technology?
It is 52.7 out of 100, which places it #17,615 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Immuno-Oncology Technology?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 0.43.
Is Immuno-Oncology Technology open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does Immuno-Oncology Technology charge a publication fee?
DOAJ records an article processing charge of US$3,490. Check the journal's website for the current fee and any waivers.